NCT04767581View on ClinicalTrials.gov

Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

March 8, 2021

Primary Completion Date

August 10, 2021

Study Completion Date

August 10, 2021

Conditions
Hyperphosphatemia
Interventions
DRUG

KHK7791

oral administration

DRUG

Placebo

oral administration

Trial Locations (1)

Unknown

Kikuchi medical clinic, Tsukuba

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT04767581 - Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis | Biotech Hunter | Biotech Hunter